Nautilus Biotechnology, Inc. (NAUT): Cash & Equivalents
$12.39M
As of 2025-12-31
$13.17M
As of 2026-06-30
-52.4%
3-year compound annual growth
-19.5%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.39M | -55.2% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $27.65M | +42.5% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $19.40M | -83.1% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $114.52M | -38.3% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $185.62M | +407.1% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $36.61M | n/a | 2022-02-24, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | 2025-12-31 | $12.39M | -55.2% |
| 908 Devices Inc. (MASS) | 2025-12-31 | $70.52M | +60.1% |
| Seer, Inc. (SEER) | 2025-12-31 | $47.28M | +16.0% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $101.82M | +2.1% |
| Quanterix Corp (QTRX) | 2025-12-31 | $29.84M | -47.4% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $8.61M | +109.7% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $90.85M | -8.0% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $20.03M | +18.4% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $2.99M | -67.4% |
Compare NAUT, MASS, SEER, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗